Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 December 2019 | Story Charlene Stanley | Photo Anja Aucamp
Sprouting Hope
Shadei Lepholletse, BSc Genetics and Physiology; Masabata Sebusi, BCom Accounting; and Tumelo Zondi, BCom Entrepreneurial Management; three of the directors of Sprout Africa, an agriculture and agri-processing company - the perceived potential of which has earned them each a place on the list of News24’s 100 Young Mandelas of the Future.

Enactus, 100 Young Mandelas of the Future, Sprout Africa, Masabata Sebusi, Shadei Lepholletse, Tumelo Zondi, and Farai Mzungu

Kovsie students’ innovative agri-processing venture is paying off. Two years ago, a seed of resolve was planted in four young UFS women. They entered the Enactus National Competition for entrepreneurship projects –and came stone last.

But instead of giving up, they re-grouped, re-evaluated their priorities, and came up with an innovative agri-processing community-upliftment concept that has earned each of them a place on News24’s list of 100 Young Mandelas of the Future.

“We asked ourselves what the big businesses out there were looking for when it came to community development. At that stage, we focused on arts and crafts and recycling. But we realised the need was for projects providing solutions around food insecurity, water management, and sustainable development,” explains Masabata Sebusi, final-year BCom Accounting student.

Masabata and her three partners, Shadei Lepholletse, Tumelo Zondi, and Farai Mzungu, are all studying in different fields. They pooled their diverse insights, knowledge, and perspectives. And Sprout Africa was born.

The company’s aim is to give people in rural communities training in modern farming techniques, equipping them with basic business skills and helping them to find an outlet for their produce. As part of the process, the women approached potential business partners – from local supermarkets to big commercial companies – to negotiate on behalf of the farmers.

This time, they seem to have struck the right nerve. Having won various grants while the concept as still an Enactus project, they have since registered Sprout Africa as a company. Various stakeholders have already shown interest to partner with them.

Their main advice to fellow entrepreneurs: Think outside the box, find innovative ways to solve problems, learn from the communities you serve, and collaborate with people who have different skills from you.

Except for Farai, who graduated earlier this year, all of them are in their final year of study. Next year, they won’t be job hunting like other new graduates. They’ll simply be stepping full time into their innovative enterprise.

An enterprise that promises to keep on sprouting and growing. And hopefully produce seeds of inspiration for other students to pick up.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept